Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 6, 2025SDÜ Tıp Fakültesi DergisiOpen Access

Evaluation of Ceftazidime-Avibactam Susceptibility in Carbapenem-Resistant Gram-Negative Bacteria

View Full Paper
Ask AI
Bookmark
Share

Authors

YŞYaren ŞekercioğluEÇEmel Sesli Çetin

Discussion

Loading...

Member takes

Overview

Analysis shows Ceftazidime-Avibactam susceptibility in multidrug-resistant bacteria, indicating a need for effective testing methods.

Key Points

  • Ceftazidime-avibactam exhibited varying susceptibility rates across different bacterial strains.
  • Rates were 74.1% for Pseudomonas aeruginosa and 64.5% for Escherichia coli, indicating notable differences between methods.
  • Assessment using both the Kirby-Bauer disk diffusion method and the BD Phoenix automated system was conducted.
  • Further species-specific studies are necessary to determine reliable susceptibility testing methods.

Cite This Study

Şekercioğlu et al. (2025) studied this question.

synapsesocial.com/papers/69337cfbb3f947a0a125a774https://doi.org/10.17343/sdutfd.1748282
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevalence, Antimicrobial Susceptibility, and Molecular Characteristics of Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae in a Chinese Hospital2026
  2. 2Antimicrobial susceptibility pattern of newer beta lactam-beta lactamase inhibitor agents on the carbapenem resistant and sensitive strains of Enterobacterales and Pseudomonas aeruginosa2024
  3. 3Change in Klebsiella pneumoniae susceptibility profile after the arrival of ceftazidime-avibactam in an Argentinean intensive care unit: a new ecological landscape2024 · 2 citations
  4. 4Assessment of <i>in vitro</i> antimicrobial activity of ceftazidime-avibactam and phenotypic synergy testing with aztreonam against carbapenem resistant Gram-negative bacilli in a tertiary care hospital2024
  5. 5Efficacy of Ceftazidime-avibactam against Multidrug-resistant Gram-negative Pathogens in ICU Patients: A Crosssectional Study from a Subhimalayan Tertiary Care Hospital2025